Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 27
Phase 41

Trial Status

Completed8
Other1

Role Distribution

Principal Investigator9
PI Rate100%

Activity Timeline

Clinical Trials (9)

NCT00000270Phase 4Withdrawn
Brain Imaging: Cocaine Effects & Medication Development - 5
Cocaine-Related Disorders
PrincipalinvestigatorStart date: 1995-12-30
NCT00000271Phase 2Completed
New Approaches to Cocaine Abuse Medications (A) - 6
Cocaine-Related DisordersSubstance-Related Disorders
PrincipalinvestigatorStart date: 1995-01-01
NCT00000266Phase 2Completed
Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1
Cocaine-Related Disorders
Principalinvestigator
NCT00000267Phase 2Completed
Risperidone Treatment in Dually-Diagnosed Individuals - 2
Cocaine-Related Disorders
Principalinvestigator
NCT00000268Not ApplicableCompleted
Cocaine Abuse and Attention Deficit Disorder - 3
Cocaine-Related Disorders
Principalinvestigator
NCT00000269Phase 2Completed
Pergolide Treatment for Substance Abusers - 4
Cocaine-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00000273Phase 2Completed
A Laboratory Model for Heroin Abuse Medications - 8
Heroin DependenceOpioid-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00000274Phase 2Completed
Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9
Cocaine-Related DisordersSubstance-Related Disorders
Principalinvestigator
NCT00000275Phase 2Completed
Cocaine Abuse and ADHD - 10
Cocaine-Related Disorders
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

New York State Psychiatric Institute

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Walter Ling, M.D.

Friends Research Institute, Inc.

Moderately Similar
28 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related DisordersHeroin Dependence+1 more

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score30%

Mark Greenwald, PhD

Wayne State University

Related
15 trials

Shared therapeutic areas:

Heroin DependenceOpioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score23%

Kenneth Silverman, Ph.D.

Johns Hopkins University

Related
8 trials

Shared therapeutic areas:

Opioid-Related DisordersHeroin DependenceCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score23%

Thomas R Kosten, M.D.

VA Connecticut Healthcare System

Related
10 trials

Shared therapeutic areas:

Cocaine-Related DisordersOpioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score23%

Charles O'Brien, M.D., Ph.D.

PDVAMC Treatment Research Center

Related
7 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Warren Bickel, Ph.D.

University of Vermont

Related
22 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Eric C. Strain, MD

Johns Hopkins University

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Kenzie Preston, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersCocaine-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Frederick Altice, MD

Yale University

Related
6 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

David Fiellin, MD

Yale University

Related
7 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (9)

Showing 9 of 9 trials

NCT00000270Phase 4PrincipalInvestigator

Brain Imaging: Cocaine Effects & Medication Development - 5

Cocaine-Related Disorders
Withdrawn
NCT00000271Phase 2PrincipalInvestigator

New Approaches to Cocaine Abuse Medications (A) - 6

Cocaine-Related DisordersSubstance-Related Disorders
Completed
NCT00000266Phase 2PrincipalInvestigator

Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1

Cocaine-Related Disorders
Completed
NCT00000267Phase 2PrincipalInvestigator

Risperidone Treatment in Dually-Diagnosed Individuals - 2

Cocaine-Related Disorders
Completed
NCT00000268Not ApplicablePrincipalInvestigator

Cocaine Abuse and Attention Deficit Disorder - 3

Cocaine-Related Disorders
Completed
NCT00000269Phase 2PrincipalInvestigator

Pergolide Treatment for Substance Abusers - 4

Cocaine-Related DisordersSubstance-Related Disorders
Completed
NCT00000273Phase 2PrincipalInvestigator

A Laboratory Model for Heroin Abuse Medications - 8

Heroin DependenceOpioid-Related DisordersSubstance-Related Disorders
Completed
NCT00000274Phase 2PrincipalInvestigator

Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9

Cocaine-Related DisordersSubstance-Related Disorders
Completed
NCT00000275Phase 2PrincipalInvestigator

Cocaine Abuse and ADHD - 10

Cocaine-Related Disorders
Completed

All 9 trials loaded